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Purpose: To investigate the relationship between spectral domain optical coherence   tomography 
(SD-OCT) findings and visual outcomes following resolution of macular edema in central retinal 
vein occlusion (CRVO).
Methods: Patients with recent onset CRVO who had undergone SD-OCT and fluorescein 
angiography (FA) exams on the day of initial presentation were included. All patients had 
  resolution of macular edema in SD-OCT images at the end of follow-up, and they were separated 
into two groups according to final visual acuity: group 1 (#20/200) and group 2 (.20/200). 
SD-OCT scans and FA studies were analyzed in a masked fashion. Macular perfusion status 
by FA was categorized according to presence or absence of macular ischemia.
Results: A total of 22 eyes from 22 patients [mean age 53.0 ± 15.0 (standard deviation)] were 
included. Mean follow up period was 14.6 ± 8.1 (standard deviation) months. Group 1 (10 eyes) 
had significantly higher rates of residual intraretinal fluid, loss of foveal inner segment/outer 
segment (IS/OS) junction line and loss of inner retinal layers in late stage SD-OCT images 
(P = 0.027) when compared with group 2 (12 eyes). Loss of foveal IS/OS junction line (odds ratio 
[OR] = 13.826; P = 0.098) and loss of inner retinal layers (OR = 38.908; P = 0.013) in late 
stage SD-OCT images were correlated with poorer final visual outcomes. Macular ischemia by 
FA correlated with thinner central subfield thickness (r = −0.54, P = 0.021) and loss of inner 
retinal layers (r = 0.47, P = 0.031) in early stage SD-OCT images; and presence of residual 
intraretinal fluid (r = 0.61, P = 0.003) and loss of inner retinal layers (r = 0.71, P , 0.001) in 
late stage SD-OCT images.
Conclusion: Loss of foveal IS/OS junction line and inner retinal layers on SD-OCT significantly 
correlated with poorer visual outcomes in CRVO patients.
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Introduction
Central retinal vein occlusion (CRVO) is a frequent retinal vascular disorder, often asso-
ciated with severe visual loss.1,2 Macular edema is the most common vision-  threatening 
complication associated with CRVO. Various options for treatment of macular edema 
secondary to CRVO have been studied, such as laser photocoagulation,3 radial optic 
neurotomy,4 and intravitreal injection of various agents including   tissue plasmino-
gen activator,5 triamcinolone acetonide,6 or anti-vascular endothelial growth factor 
agents.7,8 However, there is no proven remedy for visual loss due to CRVO.9 Despite 
the   observation that resolution of macular edema often leads to visual   improvement, 
some patients suffer persistent poor vision following complete   resolution of the 
macular edema.10Clinical Ophthalmology 2011:5 submit your manuscript | www.dovepress.com
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Optical coherence tomography (OCT) is a noncontact, 
noninvasive method that allows quantitative determination of 
retinal thickness and volume. It provides cross-sectional slice 
images of the retina and useful information on vitreoretinal 
interface changes associated with various posterior segment 
disorders.11–13 Spectral domain OCT (SD-OCT) is the latest 
generation of the technology which provides images of higher 
axial resolution and reduced motion artifacts.14–16 It permits 
accurate identification of individual retinal layers with near-
histological detail and provides significant clinicopathologi-
cal information in many retinal conditions.17,18 A number of 
recent OCT studies have identified that continuity of the 
photoreceptor inner segment/outer segment (IS/OS) junc-
tion line in the fovea is a hallmark of foveal photoreceptor 
integrity, which is critical to visual outcome in eyes with 
disorders such as branch retinal vein occlusion (BRVO)19–21 
and CRVO.10 However, there is scant information in the 
literature unraveling the relationship between specific retinal 
structural changes recorded in SD-OCT images and visual 
outcomes in eyes with CRVO.
In the current study, we investigated whether early and 
late SD-OCT findings, such as loss of inner retinal layers and 
foveal IS/OS junction status, correlated with visual   acuity 
  following resolution of macular edema in patients with 
CRVO. Additionally, we looked at the relationship between 
macular perfusion revealed by fluorescein angiography (FA) 
and its association with those SD-OCT findings.
Methods
A retrospective chart review was conducted surveying the 
imaging database for patients with CRVO who underwent 
both SD-OCT and FA exam during initial clinical evaluation 
at the Retina Service of The New York Eye and Ear Infirmary, 
between September 2006 and September 2008. The study was 
approved by the Institutional Review Board of the New York 
Eye and Ear Infirmary.
Patients with CRVO, who presented within 1 month 
of onset of symptoms, were included in the study. Patients 
had to have at least 6 months of follow-up, and resolution 
of macular edema on clinical exam, and by the SD-OCT 
(central foveal thickness ,250 µm) at the end of this period. 
Eyes with poor quality SD-OCT scans or FA images, or 
patients with macular edema caused by other etiologies 
such as diabetic retinopathy, postoperative or inflamma-
tory cystoid macular edema, were excluded. In patients 
with bilateral CRVO, one eye was selected randomly to 
be included. Medical records of all eligible patients were 
reviewed, and demographics, systemic comorbidities, and 
treatments   performed were recorded. Best corrected Snellen 
visual acuity   measurements recorded during the initial visit 
and following resolution of macular edema were collected. 
Initial best corrected visual acuity (BCVA) was defined as 
that recorded during initial presentation to our service. Final 
BCVA was taken as the one recorded at follow-up examina-
tion after resolution of macular edema. Based upon the final 
BCVA, patients were separated into two groups: group 1 
(BCVA # 20/200) and group 2 (BCVA . 20/200).
The SD-OCT (Spectral OCT/SLO, OPKO/OTI, 
Miami, FL) device used in this study had transverse and 
axial resolutions of 20 and 5–6 µm, respectively.   Individual 
cross-section images covered a field of 29° and came with 
a paired scanning laser ophthalmoscopy (SLO) image 
displaying the origin of the slice. Images considered 
acceptable in quality were evaluated by two masked retina 
specialists for evidence of predefined macular abnormali-
ties and central retinal thickness. Integrity of the foveal 
photoreceptor layer was evaluated using high quality raw 
grayscale SD-OCT scans to determine the condition of the 
IS/OS junction line. Eyes were classified as having loss of 
the IS/OS   junction when this line was totally absent in the 
fovea. In all patients, SD-OCT scans to evaluate macular 
thickness and to assess effectiveness of treatment during 
follow-up were performed until they met the satisfaction 
of the operator, an ophthalmologist with extensive imaging 
experience. Early stage and late stage   SD-OCT findings 
refer to those macular changes recorded in the SD-OCT 
images taken during the initial visit and   following resolu-
tion of macular edema, respectively.
FA assessment of macular ischemia was interpreted 
by one masked observer, and studies were separated into 
two categories, according to the presence or absence of 
macular ischemia. The patients with foveal avascular zones 
(FAZs) $1000 µm, or broken perifoveal capillary rings at the 
borders of the FAZ or distinct areas of capillary   nonperfusion 
within one disk diameter of the foveal center, as judged in 
FA transit phase frames, were regarded as having macular 
ischemia.22
statistical analysis
Chi-square analysis was used for categorical data, and 
the independent sample student t-test was used for con-
tinuous data to determine whether significant differences 
appeared between groups 1 and 2. Fisher’s exact test was 
used when one or more of the cells in chi-square analysis 
had expected values below 5. All clinical manifestations, 
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were submitted for analysis. A two-tailed P-value of ,0.05 
was considered statistically significant. Logistic regres-
sion model was used to evaluate the risk factors for poorer 
visual   outcome (BCVA # 20/200). Potential risk factors 
including age, initial visual acuity, and SD-OCT findings 
that showed differences which were statistically signifi-
cant between groups were analyzed by backward   stepwise 
  regression.   Factors with P-value .0.05 were removed from 
the   equation. Spearman’s correlation coefficient was used 
to analyze the relationship between SD-OCT findings and 
macular ischemia by FA. All data were analyzed using SPSS 
Program Package Version 15.0 (SPSS Inc., Chicago, IL). 
Logistic regression power was calculated using PASS 2008 
(NCSS, Kaysville, UT) software.
Results
Twenty-two patients (22 eyes) diagnosed with CRVO were 
included [9 female and 13 male; mean age of 53.0 ± 15.0 
(standard deviation) years]. Co-morbidities included sys-
temic arterial hypertension (45%), dyslipidemia (23%), type 
2 diabetes mellitus (9%), and acquired immunodeficiency 
syndrome (4.5%). Treatment modalities used for macular 
edema included intravitreal injections of bevacizumab in 
10 (45%) eyes and triamcinolone acetonide in four (18%) 
eyes. Multiple injections had been administered if required 
for resolution of the macular edema. Five eyes in group 2 had 
received no treatment for macular edema due to good vision 
at presentation. Peripheral panretinal photocoagulation was 
performed in 6 (27%) eyes. Two eyes developed neovascular 
glaucoma despite laser treatment. The mean follow-up period 
for all patients was 14.6 ± 8.1 (standard deviation) months 
(range, 7–42 months). Foveal thickness and central subfield 
thickness could not be determined on early stage SD-OCT in 
three patients due to severe macular edema beyond the range 
of the instrument (2.0 mm maximum depth). FA images of 
one patient were missing. This patient was excluded from the 
analysis of the relationship between the macular perfusion 
status and SD-OCT findings.
Among the 22 eyes included, 10 (45%) eyes had 
final BCVA # 20/200 (group 1), and 12 (55%) eyes had 
final BCVA . 20/200 (group 2). Table 1 summarizes 
clinical characteristics, SD-OCT findings, and macular 
perfusion status for each group. There were no statistically 
significant differences in age, gender, and initial visual acuity 
between groups. There were also no significant differences 
in foveal thickness and central subfield thickness between 
the two groups before and after resolution of macular edema. 
The main findings analyzed in the SD-OCT scans were 
  retention of hyperreflectivity of the inner layers, presence 
of   intraretinal fluid, presence of serous retinal detachment, 
loss of foveal IS/OS junction, and loss of inner retinal layers 
(Figures 1 and 2).
Statistical analysis showed that eyes in group 1 had 
higher rates of residual intraretinal fluid (P = 0.027), loss of 
foveal IS/OS junction (P = 0.020) and loss of inner retinal 
layers (P = 0.002) in late stage SD-OCT images compared 
with those in group 2. To determine the risk factors for 
poorer visual outcome (BCVA # 20/200), the SD-OCT 
findings described above, along with age and initial visual 
acuity, were analyzed using a logistic regression model. 
Among all findings analyzed, loss of foveal IS/OS junction 
line (odds ratio [OR] = 13.826; P = 0.098; 95% confidence 
interval [CI]: 0.616–310.321) and loss of inner retinal 
  layers (OR = 38.908; P = 0.013; 95% CI: 2.169–698.087) 
in late stage SD-OCT images correlated with poorer visual 
outcomes. The power of this logistic regression model 
was 0.703.
Group 1 had more eyes with macular ischemia by FA at 
initial presentation when compared with group 2 (P = 0.009). 
Table 2 summarizes the SD-OCT findings in eyes with and 
without macular ischemia by FA. Macular ischemia by FA 
showed significant correlation with the following SD-OCT 
findings: thinner central subfield thickness (r = −0.54, 
P = 0.021) and loss of inner retinal layers (r = 0.47, P = 0.031) 
in early stage SD-OCT images; and presence of residual 
intraretinal fluid (r = 0.61, P = 0.003) and loss of inner retinal 
layers (r = 0.71, P , 0.001) in late stage SD-OCT images.
Discussion
In this study we found that loss of foveal IS/OS junc-
tion line and absence of inner retinal layers in late stage 
  SD-OCT images were significantly correlated with poor 
visual outcomes in patients with CRVO. Additionally, loss 
of inner retinal layers in late stage SD-OCT images cor-
related significantly with macular ischemia diagnosed in 
early FA studies.
Currently, agents such as intravitreal triamcinolone 
acetonide or bevacizumab have been shown to be effective 
for reducing the macular edema associated with CRVO.6–8 
In most cases, reduction of macular edema is associated 
with visual acuity improvement. However, only some 
patients are able to achieve full recovery of vision follow-
ing resolution of macular edema, and others experience 
only limited visual improvement despite “successful” 
treatment. In fact, the relationship between central retinal 
thickness and visual acuity has not been well established Clinical Ophthalmology 2011:5 submit your manuscript | www.dovepress.com
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in cases of CRVO. Scott et al23 demonstrated that the 
  correlation between   OCT-measured center point thickness, 
and visual acuity letter score was statistically significant, 
but this relationship was, at best, modest in patients with 
macular edema associated with retinal vein occlusions. 
In our study, there was a trend, though not significant 
  statistically, for patients with poorer visual outcomes 
to have had thinner mean foveal thickness and   central 
subfield thickness in both early and late stage   SD-OCT 
imaging when compared with patients achieving better 
Table 1 Demographic and clinical characteristics of each group of patients with central retinal vein occlusion
Group 1 
(final VA # 20/200)
Group 2 
(final VA . 20/200)
P valuea
number of patients 10 12
Age (years, mean ± sD) 59.6 ± 12.8 47.6 ± 14.9 0.059
gender (female:male) 3:7 6:6 0.415
Systemic diseases
hypertension 6 5 0.392
Dyslipidemia 2 0 0.195
Diabetes mellitus 2 0 0.195
Duration of CrVO [median (range)] 1 month (2 days to 3 months) 2 weeks (0 day to 1 month)
Initial VA
#20/200 9 7
0.162
.20/200 1 5
Early stage SD-OCT findings
Foveal thickness (µm, mean ± sD) 395 ± 183 488 ± 179 0.281
Central subfield thickness (µm, mean ± sD) 405 ± 136 473 ± 107 0.245
Hyperreflectivity inner layer 9 12 0.455
Intraretinal fluid 10 12 –
serous retinal detachment 5 5 1.000
Loss of foveal is/Os junction 2 3 1.000
Loss of inner retinal layers 3 0 0.078
Late stage SD-OCT findings
Foveal thickness (mean ± sD) 130 ± 97 155 ± 102 0.574
Central subfield thickness (mean ± sD) 182 ± 76 207 ± 101 0.524
Hyperreflectivity inner layer 2 2 1.000
Residual intraretinal fluid 7 2 0.027b
serous retinal detachment 0 0 –
Loss of foveal is/Os junction 6 1 0.020b
Loss of inner retinal layers 8 1 0.002b
Macular ischemia on FA 7 2 0.009b
Notes:  aChi-square analysis or Fisher’s exact test was used for categorical data, and independent sample student t-test was used for continuous data.  bA two-tailed 
P value of ,0.05 was considered statistically significant.
Abbreviations: FA, fluorescein angiography; SD, standard deviation; SD-OCT, spectral domain optical coherence tomography; VA, visual acuity.
Figure 1 Fluorescein angiography (20.9 seconds) of one patient with recent onset 
central retinal vein occlusion in the right eye showing no evidence of ischemia in the 
macula (left). gray-scale spectral domain optical coherence tomography (sD-OCT) 
horizontal scan at the initial visit (upper right) demonstrates prominent macular 
edema with cystoid spaces and serous retinal detachment under the fovea. The 
snellen  best  corrected  visual  acuity  was  20/200  at  this  point.  This  patient  was 
treated with multiple intravitreal injections of bevacizumab. gray-scale sD-OCT 
horizontal scan at the final visit (lower right) shows that macular edema has resolved 
completely. The inner segment/outer segment (IS/OS) junction can still be identified 
in the fovea, and there is a complete preservation of the inner retinal architecture. 
Visual acuity improved to 20/25 at final visit.
Figure 2 Fluorescein angiography (35.1 seconds) of another patient with recent 
onset central retinal vein occlusion in the right eye revealing ischemia in the macular 
area (left). gray-scale spectral domain optical coherence tomography (sD-OCT) 
vertical scan at the initial visit (upper right) demonstrates the presence of a discrete 
amount of subretinal fluid under the fovea and loss of inner retinal layers. Visual 
acuity was counting fingers at this point. This patient was treated with an intravitreal 
injection  of  bevacizumab  and  panretinal  photocoagulation.  gray-scale  sD-OCT 
vertical scan at the final visit (lower right) shows resolution of subretinal fluid under 
the fovea. The inner segment/outer segment (IS/OS) cannot be identified in the 
fovea and there is loss of the normal inner retina architecture. Visual acuity was 
20/400 at final visit.Clinical Ophthalmology 2011:5 submit your manuscript | www.dovepress.com
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visual   outcomes. More importantly, macular ischemia 
by FA was significantly correlated with thinner central 
subfield thickness in early stage SD-OCT images. This 
appeared to go along with atrophic changes in the retina of 
those patients due to the macular ischemia. Thus, macular 
thickness alone, in this study, did not appear to be a good 
predictor of visual outcome in patients with CRVO.
According to histologic reports of eyes with retinal vein 
occlusions, edema appears at the level of the outer nuclear 
layer and is associated with liquefaction necrosis which 
may result in photoreceptor loss and contribute to foveal 
  dysfunction.24 Previous studies using earlier third-generation 
time domain OCT devices found that IS/OS junction integrity 
at the fovea was closely associated with visual acuity in eyes 
with BRVO19–21 and CRVO.10 Most of these studies evaluated 
the status of the IS/OS junction line following resolution 
of macular edema as a possible hallmark of integrity of the 
photoreceptors layer and predictor of function. In the current 
study, using a faster and higher resolution SD-OCT device, 
which provided better visualization of the IS/OS junction, 
we were additionally able to resolve concurrent loss of inner 
retinal layers, which correlated with poor visual outcomes 
in these CRVO eyes.
The ability of SD-OCT technology to differentiate 
changes in individual retinal layers allowed us to correlate 
poorer visual outcome specifically to loss of inner retinal 
layers. This goes along with the pathophysiology of CRVO 
which has its greatest impact on the circulation of the inner 
retinal layers. Histopathological studies of areas of capillary 
nonperfusion following retinal vein occlusion have revealed 
the presence of inner ischemic atrophy with loss of inner 
plexiform and inner nuclear layers.25–27 These are consistent 
with the SD-OCT appearance of inner retinal architecture 
disappearance in patients with more severe macular isch-
emia and limited visual recovery. It also agrees with the 
statistically significant correlation between the finding of 
macular ischemia by FA and the loss of inner retinal layers 
on SD-OCT.
It is still unclear at what point these retinal structural 
changes occur in the course of CRVO. We were unable to 
demonstrate any difference in early stage SD-OCT image 
findings between groups 1 and 2. This suggests that some 
time interval is required before structural changes such as 
loss of IS/OS junction line and loss of inner retinal   layers 
occur. In addition, during acute stages of the disease, 
visualization of the retinal morphology is often impaired 
due to scattering blur produced by intraretinal fluid and 
shadow artifacts caused by hemorrhage. These limitations 
mirror the difficulties diagnosing macular ischemia by FA 
in very hemorrhagic occlusions. Given the complementary 
nature of the information received from the two studies, its 
clear that SD-OCT and FA exams together provide a more 
complete clinical assessment for management of patients 
with CRVO.
Table 2 Comparison between eyes with and without macular ischemia on FA
Macular ischemia on FA
Absent (%) Present (%) P valuea
number of eyes 12 9
Early stage SD-OCT findings
Foveal thickness (µm, mean ± sD) 527 ± 195 362 ± 122 0.054
Central subfield thickness (µm, mean ± sD) 500 ± 115 383 ± 105 0.041b
Hyperreflectivity inner layer 12 (100) 8 (89)  0.258
Intraretinal fluid 12 (100) 9 (100) –
serous retinal detachment 7 (58) 2 (22) 0.108
Loss of foveal is/Os junction 3 (25) 2 (22) 0.890
Loss of inner retinal layers 0 (0) 3 (33) 0.031b
Late stage SD-OCT findings
Foveal thickness (µm, mean ± sD) 148 ± 109 148 ± 87 0.993
Central subfield thickness (µm, mean ± sD) 205 ± 193 193 ± 71 0.778
Hyperreflectivity inner layer 2 (17) 2 (22) 0.763
Residual intraretinal fluid 2 (17) 7 (78) 0.003b
serous retinal detachment 0 (0) 0 (0) –
Loss of foveal is/Os junction 3 (25) 4 (44) 0.375
Loss of inner retinal layers 1 (8) 7 (78) ,0.001b
Notes:  aSpearman’s  correlation  coefficient  was  used  to  analyze  the  relationship  between  the  SD-OCT  findings  and  the  macular  ischemia  on  FA.  bA  two-tailed   
P value of ,0.05 was considered statistically significant.
Abbreviations: FA, fluorescein angiography; SD, standard deviation; SD-OCT, spectral domain optical coherence tomography.Clinical Ophthalmology 2011:5 submit your manuscript | www.dovepress.com
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In previous reports, initial visual acuity was often found 
to be the most reliable prognostic factor for predicting visual 
prognosis in eyes with CRVO.1,2,28 It is, however, occasionally 
misleading due to transient macular edema or intraretinal 
  hemorrhage. In our study, we similarly found that patients with 
poorer initial visual acuity were more likely to have worse long-
term visual outcomes, but the correlation was not statistically 
significant, perhaps due to our small sample size.
Using multiple regression analysis, loss of the foveal 
IS/OS junction line and loss of inner retinal layers came up 
as risk factors for poorer visual outcome. Macular ischemia 
was not included in this particular regression model because it 
was highly correlated with loss of inner retinal layers. Given 
that our purpose was to focus on SD-OCT abnormal findings 
in relation to CRVO visual outcomes, we chose inner retinal 
layer loss instead of macular ischemia by FA to include in 
the regression analysis.
There were certain limitations to our study. First, it is 
based upon a relatively small sample size. Second, it is a 
retrospective chart review. And finally, it included patients 
treated with a variety of treatment modalities including 
intravitreal injections of bevacizumab and triamcinolone 
and panretinal photocoagulation. A small number of patients 
(5 eyes) did not receive any kind of treatment, and all of them 
were in group 2. Each of these courses of management could 
potentially influence visual outcome to different extents. 
However, at the point of analysis, all patients were free of 
edema both clinically and by SD-OCT exam.
In summary, loss of the foveal IS/OS junction line and 
loss of inner retinal layers in late stage SD-OCT images in 
eyes with CRVO significantly correlated with poorer visual 
outcomes. In addition, the absence of inner retinal layers 
strongly correlated with the finding macular ischemia by FA. 
This suggests that SD-OCT can be an important tool both for 
the evaluation and management of macular edema as well as 
helping to predict long-term visual prognosis in patients with 
CRVO, based on these specific structural changes. Judgment 
as to whether SD-OCT structural predictions are better than 
current clinical assessments must be reserved pending larger 
prospective trials.
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